| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine phosphatase activity | 1.89e-05 | 12 | 90 | 3 | GO:0004726 | |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 6.01e-05 | 3 | 90 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 6.01e-05 | 3 | 90 | 2 | GO:0009674 | |
| Domain | Na/K/Cl_cotranspt | 2.19e-05 | 2 | 88 | 2 | IPR002443 | |
| Domain | AAA | 6.10e-05 | 144 | 88 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 6.10e-05 | 144 | 88 | 6 | IPR003593 | |
| Domain | AA_permease_N | 6.56e-05 | 3 | 88 | 2 | IPR013612 | |
| Domain | AA_permease_N | 6.56e-05 | 3 | 88 | 2 | PF08403 | |
| Domain | SLC12A_fam | 4.54e-04 | 7 | 88 | 2 | IPR004842 | |
| Domain | SLC12_C | 6.03e-04 | 8 | 88 | 2 | IPR018491 | |
| Domain | DHC_N1 | 6.03e-04 | 8 | 88 | 2 | PF08385 | |
| Domain | SLC12 | 6.03e-04 | 8 | 88 | 2 | PF03522 | |
| Domain | Dynein_heavy_dom-1 | 6.03e-04 | 8 | 88 | 2 | IPR013594 | |
| Domain | PTPc | 6.45e-04 | 36 | 88 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_1 | 7.28e-04 | 86 | 88 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 7.60e-04 | 87 | 88 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 7.60e-04 | 87 | 88 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_PTP | 8.17e-04 | 39 | 88 | 3 | PS50055 | |
| Domain | - | 9.37e-04 | 92 | 88 | 4 | 3.90.190.10 | |
| Domain | PTPase_domain | 9.47e-04 | 41 | 88 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 9.47e-04 | 41 | 88 | 3 | PF00102 | |
| Domain | Ephrin_rec_like | 1.17e-03 | 11 | 88 | 2 | PF07699 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.23e-03 | 99 | 88 | 4 | IPR029021 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 1.93e-03 | 14 | 88 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 1.93e-03 | 14 | 88 | 2 | PS00790 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.93e-03 | 14 | 88 | 2 | IPR024317 | |
| Domain | Tyr_kinase_rcpt_V_CS | 1.93e-03 | 14 | 88 | 2 | IPR001426 | |
| Domain | Dynein_HC_stalk | 1.93e-03 | 14 | 88 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.93e-03 | 14 | 88 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.93e-03 | 14 | 88 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.93e-03 | 14 | 88 | 2 | IPR011704 | |
| Domain | EphA2_TM | 1.93e-03 | 14 | 88 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 1.93e-03 | 14 | 88 | 2 | IPR001090 | |
| Domain | Eph_TM | 1.93e-03 | 14 | 88 | 2 | IPR027936 | |
| Domain | EPH_lbd | 1.93e-03 | 14 | 88 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 1.93e-03 | 14 | 88 | 2 | PF01404 | |
| Domain | MT | 1.93e-03 | 14 | 88 | 2 | PF12777 | |
| Domain | AAA_8 | 1.93e-03 | 14 | 88 | 2 | PF12780 | |
| Domain | Tyr_kinase_ephrin_rcpt | 1.93e-03 | 14 | 88 | 2 | IPR016257 | |
| Domain | EPH_LBD | 1.93e-03 | 14 | 88 | 2 | PS51550 | |
| Domain | AAA_5 | 1.93e-03 | 14 | 88 | 2 | PF07728 | |
| Domain | DHC_fam | 2.21e-03 | 15 | 88 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 2.21e-03 | 15 | 88 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.21e-03 | 15 | 88 | 2 | IPR004273 | |
| Domain | PTPc_motif | 2.72e-03 | 59 | 88 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.72e-03 | 59 | 88 | 3 | IPR003595 | |
| Domain | AA-permease/SLC12A_dom | 4.77e-03 | 22 | 88 | 2 | IPR004841 | |
| Pubmed | Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. | 1.73e-08 | 3 | 91 | 3 | 16866365 | |
| Pubmed | Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse. | 1.73e-08 | 3 | 91 | 3 | 15222482 | |
| Pubmed | Subcellular localization of intracellular protein tyrosine phosphatases in T cells. | 6.18e-06 | 14 | 91 | 3 | 10940933 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 23643964 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 38519941 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 29619269 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15265922 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 34363021 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 38082368 | ||
| Pubmed | Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. | 6.77e-06 | 2 | 91 | 2 | 9790983 | |
| Pubmed | Characterization of an intelectin-1 (Itln1) knockout mouse model. | 6.77e-06 | 2 | 91 | 2 | 36072603 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 36192726 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16814616 | ||
| Pubmed | Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. | 6.77e-06 | 2 | 91 | 2 | 26714927 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 28224996 | ||
| Pubmed | Increased Slc12a1 expression in β-cells and improved glucose disposal in Slc12a2 heterozygous mice. | 6.77e-06 | 2 | 91 | 2 | 26400961 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 26148048 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 33647262 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24344126 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19179460 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 7929272 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 8640224 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24768874 | ||
| Pubmed | PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodelling. | 6.77e-06 | 2 | 91 | 2 | 26644181 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 9672238 | ||
| Pubmed | Intelectin1 ameliorates macrophage activation via inhibiting the nuclear factor kappa B pathway. | 6.77e-06 | 2 | 91 | 2 | 34866068 | |
| Pubmed | Human homologs of the Xenopus oocyte cortical granule lectin XL35. | 6.77e-06 | 2 | 91 | 2 | 11181563 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 24008762 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 37882238 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 11313366 | ||
| Pubmed | 1.22e-05 | 193 | 91 | 6 | 19343046 | ||
| Pubmed | Role of lactoferrin and its receptors on biliary epithelium. | 2.03e-05 | 3 | 91 | 2 | 29550924 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16936804 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 27939291 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 8663127 | ||
| Pubmed | Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7. | 2.03e-05 | 3 | 91 | 2 | 37344704 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23466610 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 19665576 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 29794429 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 36413219 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16204241 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TPST2 TMEM120B CELSR2 WDR70 CTDP1 CBLC GRID1 SENP2 CFAP43 DNMBP PKN3 PCNT | 3.12e-05 | 1105 | 91 | 12 | 35748872 |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 21972418 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 34174367 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20819979 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 17420014 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 25378591 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 36140829 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 19965981 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 27607575 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20822712 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 22989884 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 35152348 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 15786712 | ||
| Pubmed | 4.11e-05 | 484 | 91 | 8 | 31995728 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 4.23e-05 | 146 | 91 | 5 | 20686565 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | SLC25A24 FBP1 SLC12A2 PDLIM3 COPA RPS11 CACNA1G DDOST EPG5 KPNB1 | 5.06e-05 | 807 | 91 | 10 | 30575818 |
| Pubmed | TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. | 6.74e-05 | 5 | 91 | 2 | 17804836 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 19741008 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 26909801 | ||
| Pubmed | Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. | 6.74e-05 | 5 | 91 | 2 | 19180477 | |
| Pubmed | Strain-specific copy number variation in the intelectin locus on the 129 mouse chromosome 1. | 6.74e-05 | 5 | 91 | 2 | 21324158 | |
| Pubmed | SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1. | 6.74e-05 | 5 | 91 | 2 | 26369384 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | STK11 FBP1 SLC12A1 HPD ITLN1 VPS13C RPS11 GRID1 C5 SCEL KPNB1 | 7.04e-05 | 1016 | 91 | 11 | 19056867 |
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 7.57e-05 | 165 | 91 | 5 | 16107646 | |
| Pubmed | CACTIN PTPN9 PTPN12 SLC12A2 COPA AFG3L2 PTPN22 SENP2 DDOST PCNT KPNB1 | 9.34e-05 | 1049 | 91 | 11 | 27880917 | |
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 9.78e-05 | 34 | 91 | 3 | 19060911 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 33347437 | ||
| Pubmed | 1.41e-04 | 7 | 91 | 2 | 20353580 | ||
| Pubmed | 1.41e-04 | 7 | 91 | 2 | 19503088 | ||
| Pubmed | 1.41e-04 | 7 | 91 | 2 | 31178125 | ||
| Pubmed | 1.48e-04 | 39 | 91 | 3 | 21909109 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 PTPN12 PDLIM3 AFG3L2 WDR70 RPS11 TOP2A PKN3 PCNT KPNB1 | 1.68e-04 | 934 | 91 | 10 | 33916271 |
| Pubmed | 1.71e-04 | 105 | 91 | 4 | 23284306 | ||
| Pubmed | Disruption of MeCP2-TCF20 complex underlies distinct neurodevelopmental disorders. | 1.88e-04 | 8 | 91 | 2 | 35074918 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 1.88e-04 | 8 | 91 | 2 | 21613606 | |
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 31884020 | ||
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 12386165 | ||
| Pubmed | 2.37e-04 | 469 | 91 | 7 | 27634302 | ||
| Pubmed | 2.37e-04 | 469 | 91 | 7 | 37314180 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 2.39e-04 | 211 | 91 | 5 | 24097068 | |
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 12907755 | ||
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 19323993 | ||
| Pubmed | Identification of substrates of human protein-tyrosine phosphatase PTPN22. | 2.41e-04 | 9 | 91 | 2 | 16461343 | |
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 24285539 | ||
| Pubmed | Characterization of LGALS3 (galectin-3) as a player in DNA damage response. | 2.42e-04 | 46 | 91 | 3 | 24755837 | |
| Pubmed | Large-scale structural analysis of the classical human protein tyrosine phosphatome. | 2.58e-04 | 47 | 91 | 3 | 19167335 | |
| Pubmed | 2.77e-04 | 340 | 91 | 6 | 29478914 | ||
| Pubmed | The doublecortin gene family and disorders of neuronal structure. | 3.01e-04 | 10 | 91 | 2 | 20236041 | |
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 16869982 | ||
| Pubmed | 3.29e-04 | 51 | 91 | 3 | 20682687 | ||
| Pubmed | 3.67e-04 | 11 | 91 | 2 | 28323137 | ||
| Pubmed | Global identification of modular cullin-RING ligase substrates. | 4.34e-04 | 134 | 91 | 4 | 21963094 | |
| Pubmed | 4.39e-04 | 12 | 91 | 2 | 19090619 | ||
| Pubmed | Wnt signalling induces maturation of Paneth cells in intestinal crypts. | 4.39e-04 | 12 | 91 | 2 | 15778706 | |
| Pubmed | 5.18e-04 | 13 | 91 | 2 | 23847689 | ||
| Pubmed | 6.04e-04 | 14 | 91 | 2 | 25191221 | ||
| Pubmed | K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. | 6.73e-04 | 65 | 91 | 3 | 29378950 | |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 6.73e-04 | 65 | 91 | 3 | 27453043 | |
| Pubmed | Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk. | 6.95e-04 | 15 | 91 | 2 | 20233754 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.17e-05 | 18 | 63 | 3 | 812 | |
| GeneFamily | Doublecortin superfamily | 5.28e-04 | 10 | 63 | 2 | 1369 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.06e-03 | 14 | 63 | 2 | 1095 | |
| GeneFamily | Dyneins, axonemal | 1.57e-03 | 17 | 63 | 2 | 536 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-03 | 160 | 63 | 4 | 555 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN | 5.74e-06 | 199 | 90 | 7 | M9532 | |
| Coexpression | BUSSLINGER_DUODENAL_PANETH_CELLS | 1.73e-05 | 15 | 90 | 3 | M40030 | |
| Coexpression | CHEN_LIVER_METABOLISM_QTL_CIS | 2.37e-05 | 99 | 90 | 5 | MM827 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 170 | 91 | 6 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-06 | 170 | 91 | 6 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 173 | 91 | 6 | 26bba58f9fb215d1d155504906cd77e8774f6936 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 173 | 91 | 6 | 69b404e92aad3e6dff67e75466f073f20a71f13f | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 176 | 91 | 6 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 191 | 91 | 6 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.34e-06 | 127 | 91 | 5 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 141 | 91 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 141 | 91 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 148 | 91 | 5 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 148 | 91 | 5 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 154 | 91 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-05 | 154 | 91 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.72e-05 | 156 | 91 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.19e-05 | 164 | 91 | 5 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.38e-05 | 167 | 91 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 91 | 5 | 74dc46738f1d0a448df6c9b8288b515d92697792 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 169 | 91 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.67e-05 | 171 | 91 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-new-cluster|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 174 | 91 | 5 | 718e14d9a4264456459bec4c062c94c3a848d43a | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 175 | 91 | 5 | 61fdafba120fbda063d4dc05263d6f8d1dcab1e1 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 175 | 91 | 5 | 8de8031fdf2af187642833feb80caa64932897cf | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 176 | 91 | 5 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.24e-05 | 178 | 91 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-05 | 179 | 91 | 5 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-05 | 179 | 91 | 5 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-05 | 184 | 91 | 5 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.79e-05 | 184 | 91 | 5 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.79e-05 | 184 | 91 | 5 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.79e-05 | 184 | 91 | 5 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.79e-05 | 184 | 91 | 5 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.79e-05 | 184 | 91 | 5 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 3.79e-05 | 184 | 91 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 91 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 3.79e-05 | 184 | 91 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.79e-05 | 184 | 91 | 5 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 3.79e-05 | 184 | 91 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.79e-05 | 184 | 91 | 5 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.89e-05 | 185 | 91 | 5 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.09e-05 | 187 | 91 | 5 | 1bba994aaaa9825b54aaeaff3829850267bc4602 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.09e-05 | 187 | 91 | 5 | d6ac351e7aeba98851d308c14ac395044fe4fbbb | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.20e-05 | 188 | 91 | 5 | 38a53f99f1876359983936403aefca93281d10fd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.20e-05 | 188 | 91 | 5 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.20e-05 | 188 | 91 | 5 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.20e-05 | 188 | 91 | 5 | e82104f71bcdab7392fdb076dc3560255964fd9e | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-05 | 189 | 91 | 5 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-05 | 189 | 91 | 5 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-05 | 189 | 91 | 5 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.41e-05 | 190 | 91 | 5 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 191 | 91 | 5 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.53e-05 | 191 | 91 | 5 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 191 | 91 | 5 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.53e-05 | 191 | 91 | 5 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 191 | 91 | 5 | b5374674312ff5803a1d369f5533027532344679 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 191 | 91 | 5 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.53e-05 | 191 | 91 | 5 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 191 | 91 | 5 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 191 | 91 | 5 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.53e-05 | 191 | 91 | 5 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 4.53e-05 | 191 | 91 | 5 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-05 | 191 | 91 | 5 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 4.53e-05 | 191 | 91 | 5 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-05 | 191 | 91 | 5 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 192 | 91 | 5 | 6c269d2426f76559d2ed3bf2169eb4be5fc7ad6d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 194 | 91 | 5 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-05 | 194 | 91 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.99e-05 | 195 | 91 | 5 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.12e-05 | 196 | 91 | 5 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 5.12e-05 | 196 | 91 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 5.12e-05 | 196 | 91 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 197 | 91 | 5 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.37e-05 | 198 | 91 | 5 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | fd6b4ff4330db11c03f1eb4e06b43a162326f744 | |
| ToppCell | Biopsy_IPF-Epithelial-Differentiating_Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 5.63e-05 | 200 | 91 | 5 | 8dfce65e417d6dcacb871d93d1539cdf807002fe | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 5.63e-05 | 200 | 91 | 5 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | 8795920911ee75c09a97cc948c14ad7301b27796 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.63e-05 | 200 | 91 | 5 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 5.63e-05 | 200 | 91 | 5 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.63e-05 | 200 | 91 | 5 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.67e-05 | 110 | 91 | 4 | b9c8014fd2820e5ea28a7e02fd24227b99e71eb3 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-05 | 110 | 91 | 4 | 3a641dced828ed97a8eea70d0a7b76f33630c9be | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE-P2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.67e-05 | 110 | 91 | 4 | ee45592e936d32881c0f3429c21360670e5b3ce3 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.26e-04 | 125 | 91 | 4 | 6cd741dd1c7ee6b16437cca7c15c99b5c95603fc | |
| ToppCell | TCGA-Mesothelium|World / Sample_Type by Project: Shred V9 | 1.46e-04 | 130 | 91 | 4 | 3ef1733eb57e2a9a3298ce0d65401f19e2084df1 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.74e-04 | 53 | 91 | 3 | 3549c9cdb138b01295b6a9745062fa3e4bd2e5dc | |
| ToppCell | Club-club-1|World / Class top | 1.84e-04 | 54 | 91 | 3 | 48f80b20b1c4995a0f7084d31666781dce4009a9 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.84e-04 | 54 | 91 | 3 | 98b31718fa200432cf86b59a52484da101219f96 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.84e-04 | 54 | 91 | 3 | 872e7374dac64be2c8ebe71e88a2ec6814168d89 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.00e-04 | 141 | 91 | 4 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 142 | 91 | 4 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 146 | 91 | 4 | 24e63124116b9a6796ae0495fc69dc6b6af28c38 | |
| ToppCell | droplet-Liver-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 146 | 91 | 4 | d9df42f8e44018b149a84f07c540cdba74d6374a | |
| ToppCell | droplet-Liver-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 146 | 91 | 4 | a9fa64617c7fb7a66de77360c5642c1da91e465c | |
| ToppCell | droplet-Liver-Npc-21m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 146 | 91 | 4 | ae43d418492177546b7f85afffb4287d40815f88 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 146 | 91 | 4 | e03658ead410d003e2b18fe94da086a38560b8e7 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 1.65e-06 | 120 | 88 | 6 | EFO_0004611, EFO_0004639 | |
| Disease | level of intelectin-1 in blood serum | 8.79e-06 | 2 | 88 | 2 | OBA_2044678 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 9.37e-06 | 94 | 88 | 5 | EFO_0008595, EFO_0010351 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 1.04e-05 | 96 | 88 | 5 | EFO_0004529, EFO_0008595 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.21e-05 | 99 | 88 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 1.21e-05 | 99 | 88 | 5 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 1.21e-05 | 99 | 88 | 5 | EFO_0004639, EFO_0008595 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.40e-05 | 102 | 88 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 1.53e-05 | 104 | 88 | 5 | EFO_0008591, EFO_0008595 | |
| Disease | free cholesterol measurement | 2.29e-05 | 113 | 88 | 5 | EFO_0008591 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 2.39e-05 | 114 | 88 | 5 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 2.39e-05 | 114 | 88 | 5 | EFO_0004574, EFO_0004611 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.50e-05 | 303 | 88 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | cystic fibrosis (is_marker_for) | 3.61e-05 | 62 | 88 | 4 | DOID:1485 (is_marker_for) | |
| Disease | esterified cholesterol measurement | 4.17e-05 | 128 | 88 | 5 | EFO_0008589 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 4.62e-05 | 66 | 88 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 5.77e-05 | 137 | 88 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | intermediate density lipoprotein measurement | 1.36e-04 | 87 | 88 | 4 | EFO_0008595 | |
| Disease | ulcerative colitis (biomarker_via_orthology) | 3.12e-04 | 9 | 88 | 2 | DOID:8577 (biomarker_via_orthology) | |
| Disease | isovalerate measurement | 3.12e-04 | 9 | 88 | 2 | EFO_0021051 | |
| Disease | serum albumin measurement | 3.94e-04 | 592 | 88 | 8 | EFO_0004535 | |
| Disease | Systemic lupus erythematosus | 4.75e-04 | 11 | 88 | 2 | cv:C0024141 | |
| Disease | 1-methylxanthine measurement | 4.75e-04 | 11 | 88 | 2 | EFO_0021174 | |
| Disease | phospholipids in IDL measurement | 5.10e-04 | 52 | 88 | 3 | EFO_0022164 | |
| Disease | total lipids in LDL measurement | 5.10e-04 | 52 | 88 | 3 | EFO_0022308 | |
| Disease | total phospholipids in lipoprotein particles measurement | 5.39e-04 | 53 | 88 | 3 | EFO_0022315 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 5.60e-04 | 126 | 88 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 5.78e-04 | 225 | 88 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | polyunsaturated fatty acid measurement | 6.48e-04 | 131 | 88 | 4 | EFO_0010733 | |
| Disease | total lipids in large LDL | 6.68e-04 | 57 | 88 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 6.68e-04 | 57 | 88 | 3 | EFO_0021901 | |
| Disease | total lipids in medium HDL measurement | 7.02e-04 | 58 | 88 | 3 | EFO_0022310 | |
| Disease | cholesterol in medium HDL measurement | 7.38e-04 | 59 | 88 | 3 | EFO_0021903 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.58e-04 | 239 | 88 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | total lipids in IDL | 7.76e-04 | 60 | 88 | 3 | EFO_0022161 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 7.76e-04 | 60 | 88 | 3 | EFO_0022282 | |
| Disease | phospholipids in HDL measurement | 8.14e-04 | 61 | 88 | 3 | EFO_0022293 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 8.94e-04 | 63 | 88 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | ovarian carcinoma (is_implicated_in) | 9.00e-04 | 15 | 88 | 2 | DOID:4001 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 9.23e-04 | 144 | 88 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.07e-03 | 67 | 88 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | SLAM family member 7 measurement | 1.16e-03 | 17 | 88 | 2 | EFO_0008287 | |
| Disease | Antibody Deficiency Syndrome | 1.16e-03 | 17 | 88 | 2 | C0003257 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 1.16e-03 | 17 | 88 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.18e-03 | 264 | 88 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | Lupus Erythematosus, Systemic | 1.27e-03 | 71 | 88 | 3 | C0024141 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 1.43e-03 | 162 | 88 | 4 | EFO_0004612, EFO_0007878 | |
| Disease | behavioural disinhibition measurement | 1.48e-03 | 75 | 88 | 3 | EFO_0006946 | |
| Disease | sphingomyelin measurement | 1.48e-03 | 278 | 88 | 5 | EFO_0010118 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 1.63e-03 | 168 | 88 | 4 | EFO_0004329, EFO_0004612 | |
| Disease | gastric ulcer (biomarker_via_orthology) | 1.78e-03 | 21 | 88 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.81e-03 | 291 | 88 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.12e-03 | 85 | 88 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | Immunologic Deficiency Syndromes | 2.14e-03 | 23 | 88 | 2 | C0021051 | |
| Disease | chronic widespread pain | 2.14e-03 | 23 | 88 | 2 | EFO_0010099 | |
| Disease | HDL cholesterol change measurement | 2.33e-03 | 24 | 88 | 2 | EFO_0007805 | |
| Disease | lipid measurement, lipoprotein measurement | 2.50e-03 | 90 | 88 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | HMG CoA reductase inhibitor use measurement | 2.50e-03 | 189 | 88 | 4 | EFO_0009932 | |
| Disease | 3-hydroxybutyrate measurement | 2.52e-03 | 25 | 88 | 2 | EFO_0010982 | |
| Disease | Acute kidney injury | 2.52e-03 | 25 | 88 | 2 | HP_0001919 | |
| Disease | primary biliary cholangitis (is_marker_for) | 2.52e-03 | 25 | 88 | 2 | DOID:12236 (is_marker_for) | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 2.58e-03 | 91 | 88 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.90e-03 | 197 | 88 | 4 | EFO_0005680 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.94e-03 | 27 | 88 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APNLITVKKYVYFQG | 311 | Q9Y5B0 | |
| AYQKYLAQKPYAGIL | 926 | Q9HCE0 | |
| YKKVQSRQYGPGLLY | 631 | Q8NDM7 | |
| QVLLEGQKDGFYLYP | 296 | Q9ULV8 | |
| KGLGYAQYLPKEQYL | 601 | Q9Y4W6 | |
| QYLDKDLYPVINGGV | 156 | P30838 | |
| KLGLVKYGEKYAGNY | 2031 | O95477 | |
| YNLDPYIQEFGIKVK | 386 | Q9UL18 | |
| HNYGPGGNKKLIYFI | 2561 | Q96DT5 | |
| LAEVNGKKGYVPSNY | 1556 | Q6XZF7 | |
| QLKYYNKPLLGQTGL | 1456 | Q9HCU4 | |
| QYYGVLGNKDLEGFK | 66 | O14678 | |
| KQKFLGQNYYKEGPE | 711 | Q01432 | |
| NANFIKGVYGPKAYI | 86 | Q9Y2R2 | |
| YKQKNAYIGTQGPLE | 366 | P43378 | |
| HNLFGIYQKYPVKYG | 181 | Q8WWA0 | |
| QKIAYLGGKGPFSYN | 236 | Q92813 | |
| LHAGPNVYKFKIRYG | 16 | Q3KP22 | |
| KLYGKSPLFGQYFVL | 306 | Q5VT66 | |
| KLKFGIGDGNLQYYL | 466 | O60551 | |
| LNDQGYLLKKGPKVY | 821 | Q9UJA3 | |
| GYILEVNRIPYGKKN | 56 | P07098 | |
| ALNGYDILEGYPKKI | 356 | P45452 | |
| LPYKKYGLEVYQSGI | 4571 | Q02817 | |
| IYSKPGGYRLFVQKL | 426 | P32455 | |
| YYLGKKFLGDLQPDG | 96 | Q8N594 | |
| KGGKYSVQFKLPDVY | 371 | P39656 | |
| YQKKYLLLLIGGFQD | 3151 | O95613 | |
| AFVAYQKYGPIIKEQ | 296 | Q96JM4 | |
| TLVYGGIFLYPANKK | 256 | P09467 | |
| LLKLLVYGPFGYIKN | 791 | O43497 | |
| GPKVVKLIKNYLQYG | 56 | Q9H1M3 | |
| YRNGDPFYVGKKFVL | 21 | A8MYV0 | |
| PFLLDYAQGAYGVKK | 251 | A0A1W2PPK0 | |
| VGQSIIAYLQKKGYP | 621 | P53621 | |
| IEPEYNFIGYKNFKN | 231 | P01031 | |
| GKDGGLPINAYFVKY | 601 | Q4KMG0 | |
| FLRKPGLKYVTYGNI | 396 | Q7Z4T8 | |
| LGKYGIKYILNVTPN | 266 | Q16829 | |
| NFQKYGPIYREKLGN | 81 | P05108 | |
| VGPVNKKGFYLAFQD | 171 | P29320 | |
| KPFLGIGLKNYAEYQ | 651 | Q14974 | |
| YTVKFQKKGDYPLFG | 341 | O43148 | |
| YVNGQLKNKYGDAFI | 51 | P62312 | |
| LGHNLFGIYQKYPVK | 191 | Q8WWU7 | |
| KALGFKYEIYQAPDG | 476 | Q9ULK0 | |
| AFLGVQAGKILLYYK | 511 | Q68CP4 | |
| KIVQGYKFNIFYPDL | 671 | Q8WUQ7 | |
| GGKYITFILDPFQYQ | 86 | O75881 | |
| NYGPPGNKKLIYFID | 2531 | Q9NYC9 | |
| RNKVGQVGYVPEKYL | 511 | O94868 | |
| RAGKPKGLAYVEYEN | 836 | Q15020 | |
| YVAGGQEAFKKLNYL | 86 | Q9UHG0 | |
| IGYGSCLFLYVKPKQ | 246 | Q8NGT5 | |
| GKVLLVQFKGTGKYY | 571 | Q6P5Z2 | |
| SAGKYDVYLINPQGK | 116 | P51608 | |
| EKLPRYYKNIGLGFK | 31 | P62280 | |
| YYKNIGLGFKTPKEA | 36 | P62280 | |
| LVEKMNYIGQFLPGY | 146 | P32754 | |
| FFYPKLKSGGYQAVK | 441 | Q9HC62 | |
| QYVLPGNKYLIKLGA | 2206 | O75445 | |
| YLGPQYVAGITNLKK | 681 | P02788 | |
| YLPKKNGLYLNLVLG | 96 | A0PK00 | |
| DFQRKPKKYGGDYLQ | 131 | Q969Y0 | |
| GVPLNYAEALKYFQK | 386 | Q5TEA6 | |
| YGGKVYFQTLPQGEL | 571 | O15197 | |
| LYFNGKEQIIYGKIP | 351 | O14793 | |
| GIYQKILAGKLYFPR | 251 | O43930 | |
| ANFIKGVYGPKAYVA | 91 | Q05209 | |
| KAKDIYNSILGPYLG | 686 | Q5VXU9 | |
| NIYKALQFFAKGYGK | 526 | Q13621 | |
| LQFFAKGYGKNNEPL | 531 | Q13621 | |
| KGYGKNNEPLRGYIL | 536 | Q13621 | |
| NLKQKGYFFIEGELY | 326 | Q53GG5 | |
| YKLFENIGKGSYAIP | 261 | Q15831 | |
| YLGYVGNLQEKVPEL | 96 | Q86X19 | |
| GDYKTPANLKGYFQV | 351 | O60704 | |
| AAYKIFLYPNAGQLK | 266 | Q99797 | |
| GNGLAKVYYDPNKSQ | 491 | Q9NW82 | |
| PKDGYQENISGKYIQ | 591 | O95171 | |
| PGAANLYQVFIKYKE | 261 | P15498 | |
| FAKGYGKNNEPLRGY | 641 | P55011 | |
| FIYAKLNPGIAYVQG | 216 | Q9NVG8 | |
| IYGLENFVYKDIKPG | 136 | Q709C8 | |
| KGFLANYIGLKFQYQ | 751 | Q86WI1 | |
| YKKGGLVINETGLYF | 176 | P48023 | |
| FLNGNKLPVKGFRSY | 256 | P11388 | |
| LGNVETGKKNPYEYI | 231 | Q6NX49 | |
| KKYQYLLGPNGELQD | 586 | Q96MP5 | |
| GQYIGPGQKIYTVKD | 331 | Q9H0C3 | |
| FYGLPKVAYIDLQKN | 356 | O60602 | |
| GAFYKGYVPNLLGII | 341 | Q6NUK1 | |
| PELQLFQAEGKIYKY | 26 | P51522 | |
| YKAGDPVILYVNKVG | 36 | O15321 |